Biomedical Market

Biodefense Market Showing 6.9% CAGR Growth to 2024: Company Profiles & Growth Analysis

Posted on Updated on

This global Biodefense market report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years.

Biodefense Market size forecast predicts over USD 17 billion in revenue by 2024; according to the latest research report.

Growing R&D spending for product innovation by key industry players and rising government research funding is expected to boost global biodefense market size. The presence of favorable federal government initiatives such as Project BioShield and Emergency Use Authorization of medical products is expected to catapult growth in the coming years. Moreover, growing threats regarding chemical, biological, and radiological warfare should heighten the need for continuous technology upgrades. The biodefense market has witnessed surge in R&D investments aimed at catering to threats involving the recent Ebola outbreak.

The emergence of technologically advanced centers for innovation in advanced development and manufacturing, continuous development of next generation detection systems such as CIP based detection, environmental detection and vulnerability detection is anticipated to drive revenue.

Global surveillance measures against the threats of bioterrorism and pandemic outbreaks has improved public health preparedness to effectively monitor and control community health. The focus is shifted towards development of precise analytical instruments, tests and procedures that detects and identifies bio threat agents. Countries have entered into mass production and stockpiling of antibiotics effective against the bacterial agents and resumed the halted offensive biological weapons programs

Protective measures implemented by international associations will serve as strategic deterrents. For instance, a treaty between U.S. and North Atlantic Treaty Organization (NATO) reinstates the commitment of the use of weapons of mass destruction against any member state would represent an attack against all NATO members. Other protective and instant response measures include development of the CDC Rapid Response and Advanced Technology laboratory, National Electronic Data Surveillance System (NEDSS), Health Alert Network (HAN), and Epidemic Information Exchange (Epi-X). These protective measures are anticipated to reduce the cost of responding to any emergency bio threat.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467775/

North America biodefense market share represented the largest regional segment in 2015. Implementation of Project BioShield coupled with presence of government and private funding are some of the factors fueling demand. Furthermore, countries such as Japan and China should experience high growth in the coming years due to advancing healthcare infrastructure, and the presence of favorable political and regulatory environment.

Key insights from the report include:

Global biodefense market size was driven by the anthrax segment, which was USD 3 billion in 2015 and is anticipated to grow at 5% from 2016 to 2024.

Revenue growth will be propelled by smallpox segment that is set to increase at 7.4% CAGR estimations to exceed USD 4 billion by 2024.

Eminent companies entered into contracts with the government for addressing a range of healthcare, scientific, national security and international security issues, which has led to high U.S. biodefense market share.

European countries of Germany and UK are set to witness lucrative growth rate due to designated funding policies in place.

Companies operating in the industry include Xoma Corporation, Emergent Biosolutions, Cleveland BioLabs, Nanotherapeutics, SIGA Technologies, etc. Presence of extensive product portfolio and strong pipeline will contribute to profitability.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467775/

Selected points from Table of Contents of this report:

Chapter 1.    Methodology and Scope

1.1.    Research Methodology

1.1.1.    Initial data exploration

1.1.2.    Statistical model and forecast

1.1.3.    Industry insights and validation

1.2.        Data Sources

Chapter 2.    Executive Summary

2.1.    Biodefense industry 360 degree synopsis, 2012 – 2024

2.1.1.    Business trends

2.1.2.    Regional trends

2.1.3.    Product trends

Chapter 3.    Biodefense Industry Insights

3.1.    Industry segmentation

3.2.    Industry Size and forecast, 2012 – 2024

3.3.    Industry Impact forces

3.3.1.  Growth drivers

3.3.1.1. Presence of favorable government initiatives

3.3.1.1.1 Project BioShield Act, 2004

3.3.1.1.2 Emergency Use Authorization of Medical Products

3.3.2.    Industry pitfalls & challenges

3.3.2.1. Low penetration in developing and underdeveloped countries

3.4.    Growth potential analysis

3.5.    Porter’s analysis

3.6.    PESTEL analysis

3.7     Market Insights, By type

3.7.1     Biological defense

3.7.2     Chemical defense product pipeline

3.7.3     Nuclear/ radiation defense product pipeline

For More Info: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Web site: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog/

Advertisements

Biopsy Devices Market Showing 6.5% CAGR Growth to 2024: Company Profiles & Growth Analysis

Posted on Updated on

This global Biopsy Devices market report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years.

Biopsy Devices Market size is estimated to see USD 3.1 billion revenues by 2024; as reported.

Growing demand for minimally invasive surgeries and disposable devices in line with increasing demand for technologically advanced, and accurate products will boost global biopsy devices market growth.

Growing prevalence of cancer and geriatric population base account for the pivotal factors is set to positively impacting the market growth. Moreover, introduction of technologically advanced products and growth in market penetration rates in Latin America and Asia Pacific should present the biopsy device manufacturers with lucrative growth opportunities in the years to come.

The emergence of technologically advanced vacuum-assisted biopsy guidance devices, and growing popularity of disposable products coupled with rising adoption of minimally invasive medical procedures indicate towards healthy growth in the biopsy devices market.

Guidance systems accounts for majority of biopsy devices market share contributing to 43% in 2015, with revenue anticipated to exceed USD 1.1 billion by 2024. Strong robotic guidance system price trend is expected to fuel growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467786/

Key insights from the report include:

Global biopsy devices market size is set to reach USD 3.1 billion by 2024, from an estimated USD 1.75 billion for 2015, projected to grow at 6.5% from 2016 to 2024.

Biopsy guidance systems dominated the overall biopsy devices market during the forecast timeframe valued at USD 755.5 million for 2015.

U.S. biopsy devices market size valued at USD 410.5 million for 2015, accounting for major regional share. High prevalence of cancer coupled with growing awareness regarding cancer diagnosis are some of the factors attributed to the major share of the region.

Germany and UK garnered 28.6% and 22.8% respectively in the Europe biopsy devices market share for 2015.

Biopsy devices market share experiences a moderately low level of new entry threat. The major players in the market take up around 80% share, and employ acquisition strategies making it difficult for the new players to sustain in the market.

China, Japan and India biopsy devices market drive Asia Pacific due to presence of large patient pool, while LATAM was driven by Brazil and Mexico.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467786/

Selected points from Table of Contents of this report:

Chapter 2.        Executive Summary

2.1.        Biopsy Devices industry 360 degree synopsis, 2012 – 2024

2.1.1.    Business trends

2.1.2.    Regional trends

2.1.3.    Product trends

Chapter 3.        Biopsy Devices Industry Insights

3.1.        Industry segmentation

3.2.        Industry Size and forecast, 2012 – 2024

3.3.        Industry Impact forces

3.3.1.    Growth drivers

3.3.1.1. Presence of huge geriatric population base

3.3.1.2. Growing prevalence of cancer

3.3.1.3. Rising need for effective diagnostic procedures

3.3.1.4. Increasing preference for minimally invasive procedures

3.3.2.    Industry pitfalls & challenges

3.3.2.1. Capital-intensive products

3.4.        Growth potential analysis

3.5.        Porter’s analysis

3.6.        PESTEL analysis

3.7         Company market Share Analysis, 2015

Chapter 4.        Biopsy Devices Product Insights

4.1        Biopsy devices market share, by product, 2015 & 2024

4.2        Needle-based biopsy guns

4.2.1     Market estimates by region, 2012 – 2024

4.2.2     Vacuum-assisted Biopsy Device

4.2.2.1  Market estimates by region, 2012 – 2024

4.2.3     Fine needle aspiration biopsy devices

4.2.3.1  Market estimates by region, 2012 – 2024

4.2.4     Core-needle biopsy devices

4.2.4.1  Market estimates by region, 2012 – 2024

4.3        Biopsy guidance systems

4.3.1     Market estimates by region, 2012 – 2024

4.3.2     Manual

4.2.3.1  Market estimates by region, 2012 – 2024

4.3.3     Robotic

For More Info: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Web site: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog/

Molecular Diagnostics Market 2017: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2024

Posted on Updated on

MarketStudyReport.com Adds New Molecular Diagnostics Market 2017 – 2024 research report providing information and By Application, By Technology, Industry Analysis, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 270 Pages with table and figures in it.

Molecular Diagnostics Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 8.4% CAGR to 2024.

Molecular Diagnostics Market is set to exceed USD 12.5 billion by 2024; according to a new research report. Growing geriatric population base along with rising incidences of infectious diseases will act as high impact rendering factors for molecular diagnostics market. Elderly people prone to suffer from several diseases require continuous monitoring as well as diagnostic tests for various diseases. Multifactorial benefits and applications of molecular diagnostics in therapeutic monitoring, detection of predisposition to disease, patient stratification, drug regimen selection and others will drive molecular diagnostics market growth.

Technological advancements including target specific PCR, high throughput capacity has escalated level of disease diagnosis in less time as compared to conventional method will favor molecular diagnostics market growth. Growing awareness about several diseases, diagnosis and prevention has stimulated demand for diagnostic tests.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467710/

Growing adoption of western culture, unhealthy dietary habits and physical inactivity has led to upsurge in several chronic disease incidences. Increasing prevalence of infectious diseases in developing countries such as India coupled with growing demand for point of care diagnostic technologies (POCT) will fuel business growth.

Growth of home healthcare sector coupled with technological advancements in handheld POCT devices will drive molecular diagnostics market growth. Rising demand for cost effective disease diagnostic tests has accelerated rise in R&D investment for development of molecular diagnostic platform. Significant role of molecular testing in diagnosis of cancer and sexually transmitted disease will positively impact industry growth.  However, complex nature of U.S. FDA approval for molecular diagnostic technology coupled with rising costs associated with molecular testing will hinder molecular diagnostics market growth over the forecast period.

Infectious disease segment held largest revenue share in 2016 and is expected to follow similar trend over the forecast timeframe due to increasing incidences of infectious diseases in developing countries of Asia Pacific and Latin America. Growing awareness about pre-disease diagnosis will fuel molecular diagnostics market growth.

U.S. molecular diagnostics market held largest revenue share in 2016 due to growing geriatric population, highly susceptible to suffer from various illnesses along with high technological adoption rate of U.S. Increasing healthcare expenditure by government as well as individual will positively impact market growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467710/

China molecular diagnostics market should grow at significant rate due to growing demand for advanced treatment coupled with rising prevalence of infectious diseases such as hepatitis in the country. Increasing number of baby boomers will act as primary driver for industry growth. Increasing focus of industry players towards expanding country’s molecular diagnostics platform coupled with rising adoption of PCR and locally manufactured diagnostic kits in the country will favor Chine molecular diagnostics market growth.

Some of the key industry players operating in global molecular diagnostics market are Abbott, Alere, Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories, Danaher Corporation, GenMark Diagnostics, HTG Molecular Diagnostics, Johnson & Johnson, MDxHealth, Novartis (Grifols), Qiagen Gaithersburg, Siemens Healthcare and Roche. Industry players are focusing their efforts towards developing new cost-effective, highly accurate and easy operative molecular diagnostic products to satisfy increasing consumer demand along with consolidate its market position. Strategic partnership, alliances, mergers and acquisitions are major strategies followed by market players.

Table of Content:

Chapter 1. Methodology

Chapter 2. Executive Summary

Chapter 3. Molecular Diagnostics Industry Insights

Chapter 4. Molecular Diagnostics Market, By Application

Chapter 5. Molecular Diagnostics Market, By Technology

Chapter 6. Molecular Diagnostics Market, By Region

Chapter 7. Company Profiles

For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

Related Report:

Global In Vitro Diagnostics (IVDs) Market Research Report 2018

This report studies the global In Vitro Diagnostics (IVDs) market status and forecast, categorizes the global In Vitro Diagnostics (IVDs) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

https://www.marketstudyreport.com/reports/global-in-vitro-diagnostics-ivds-market-research-report-2018/?utm_source=RR-PSR

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

Biosensors Market – Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2024

Posted on Updated on

MarketStudyReport.com Adds New Biosensors Market 2018 – 2024 research report providing information and By Type, By Medical Application, By Technology, By End-use, Industry Analysis, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 150 Pages with table and figures in it.

Biosensors Market Research Report for the period of 2018-2024 that shows the growth of the market is rising at a 8% CAGR to 2024.

Biosensors Market will exceed USD 29 billion by 2024; as per a new research report. Increasing prevalence of diabetes has been a major growth factor driving the biosensors industry. Increasing sedentary lifestyle and changing food habits around the world have resulted in obesity and hormonal disorders that lead to high prevalence of diabetes. Increasing demand for glucose biosensors that enable accurate detection of blood sugar levels has stimulated industry growth.

Integration of advanced technology in the newly developed biosensors will propel business growth. Growing adoption of biosensors in medical diagnostics due to accuracy and efficiency provided by newly developed biosensors will further boost biosensors market growth over the forecast timeframe.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467795/

Wearable biosensors attributed to more than 55% of the industry revenue in 2017 and is expected to grow significantly during the forecast period, owing to growing awareness amongst the adult population in developed as well as developing countries for sustaining healthy lifestyles along with rising incidences of diabetes. Industry players are focused on developing devices that will help individuals to monitor their health on various parameters.

Electrochemical segment will witness 8.5% growth over the forecast timeframe owing to increasing preference for such technology that enables quick and efficient diagnosis. Biosensors integrated with electrochemical technology also enables clear analysis and helps in minimizing errors thereby assisting in diagnostic decisions and improving overall surgical performance will drive biosensors market growth.

Pregnancy testing segment will show considerable growth during the upcoming years owing to growing number of teenage pregnancies escalating demand for pregnancy testing biosensors. In 2015, around 229,715 babies were born to women in age group of 15-19 years in the United States which has resulted in considerable increase in demand.

Home healthcare diagnostics segment will witness more than 8.5% growth over the coming years. High growth rate can be accounted to the adoption of wearable biosensors for home use. The geriatric population that suffers for various health issues prefer portable biosensors over other conventional medical procedures due to its ease of use and convenience.

U.S. biosensors Market was over USD 5.5 billion in 2017. The market growth will be driven by rising prevalence of chronic diseases such as diabetes and cancer that require continuous critical monitoring. Rising usage of portable biosensors will increase the demand and stimulate the business growth. Furthermore, extended applications of biosensors in various other fields will also enhance overall industry growth significantly.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467795/

Germany biosensors market will witness 8.2% growth over the forecast period due to development of new biosensor devices that have advanced technology integrated within them delivering improved surgical performance along with assisting in critical decisions about patient’s health. Increasing use of biosensors in medical as well as research laboratories will fuel biosensors market growth significantly.

Major industry players operating in biosensors market are Abbott Laboratories, Bio-Rad International, Biosensors International, DuPont Biosensors Materials, Ercon, Gwent Group, Innovative Biosensors, Johnson & Johnson, Molecular Devices Corp, Pinnacle Technology, QTL Biosystems, Roche Diagnostics, SDIX, LLC, Siemens Healthcare, TE Connectivity Corporation, Thermo-Fisher Scientific. Stiff competition among manufacturers have encouraged industry players to undertake some strategic initiatives to improvise their product offerings coupled with consolidating their market position.

Strategic merger and acquisition as well as new product development are some of the strategic initiatives that render companies with competitive advantage to survive in stiff competitive market. In June 2014, Johnson & Johnson developed new technology that is integrated within the biosensors that helps in monitoring critical and chronic conditions such as Alzheimer’s disease. Development of such new technologies will strengthen company’s product portfolio thereby generating profits for the company.

Table of Content:

Chapter 1. Methodology

Chapter 2. Executive Summary

Chapter 3. Biosensors Industry Insights

Chapter 4. Biosensors Market, By Type

Chapter 5. Biosensors Market, By Technology

Chapter 6. Biosensors Market, By Medical Application

Chapter 7. Biosensors Market, By End-use

Chapter 8. Biosensors Market, By Region

Chapter 9. Company Profiles

For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

Related Report:

United States Nano Biosensors Market Report 2018

 In this report, the United States Nano Biosensors market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

https://www.marketstudyreport.com/reports/united-states-nano-biosensors-market-report-2018/?utm_source=RR-PSR

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

Medical Fluid Bags Market with In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast till 2024

Posted on Updated on

 

Prevalence of chronic disease and surgery rates, medical fluid bags market stands as one of the most essential verticals of the healthcare fraternity and is witnessing exceptional demand from hospitals, blood banks, and diagnostic centers. According to the American Red Cross, in the U.S., an estimated 6.8 million people donate blood every year and over 21 million blood components are transfused, which in turn has significantly supported the demand for medical fluid bags market. Given the substantial increase in surgical procedures and a supportive reimbursement scenario, U.S. has been the forerunner and is emerging as a significant invest hub for potential stakeholders of medical fluid bags market.

Medical Fluid Bags Market Research Report for the period of 2018-2024 that shows the growth of the market is rising at a 6.5% CAGR to 2024.

Medical Fluid Bags Market will exceed USD 4.4 billion by 2024; as per a new research report. Rising aging population, leading to various age-associated diseases coupled with increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, kidney and liver disorders, will drive medical fluid bags market over the forecast timeframe.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/512056/

Numerous government and non-government initiatives has led to a rise in awareness amongst the population regarding the necessity of blood donations. These initiatives will assist the population to increasingly participate in blood donation activities that will propel industry growth. Furthermore, favorable reimbursements by Medicare and Medicaid for various fluid bags will drive medical fluid bags market over the forecast timeframe. However, ill effect on environment as well as human beings, along with fragmented industry will hinder medical fluid bags market growth during the forecast timeframe.

Drain bags segment dominated medical fluid bags market contributing to over 30% share in 2017 and is estimated to grow considerably over the forecast timeline. Increasing number of surgeries coupled with rising prevalence of chronic diseases such as kidney failure and cardiovascular diseases resulting into surgeries, will drive segment growth.

Polyolefins segment is the largest market share bearing segment, driven by superior properties such as greater thermal stability, lesser leaching levels and high-impact resistance.

This material is unreactive possessing great organoleptic properties. Due to excellent stability property, the need for chemical analyzer is eliminated thereby, increasing customer preference. Thermoplastic polyurethanes segment will grow at significant growth rate owing to higher relative biocompatibility, versatility and ease of recycling.

Blood banks segment is anticipated to witness significant growth during the forecast timeline due to rising necessity for cellular therapies, customized vaccines and blood transfusion. Growing awareness for blood donations along with secure blood storage during transportation and blood donation camps will further accelerate business growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/512056/

High medical fluid bag adoption rate and an excellent reimbursement scenario will drive the U.S. medical fluid bags market. Additionally, rising prevalence of kidney diseases that require more number of medical fluid bags will propel business growth in the country.

Germany medical fluid bags market will be driven by rising geriatric population coupled with high chronic disease occurrence. Growing tie-ups amongst the companies for gaining technological advantage will favor industry growth.

Some of the key industry competitors in medical fluid bags market Amcor, Amsino, B. Braun, Baxter, C.R.Bard, Coloplast, ConvaTec, Eagle, Fresenius Kabi, Hospira, Kawasumi Laboratories, Kraton, Maco Pharma, Pall Corporation, Renolit, Sippex, Smiths Medical, Technoflex, Terumo, Thermofisher, Vonco, Westfield Medical, Wipak. Industry players are adopting strategies such as acquisitions and collaborations in order to expand their product base and thereby increase company revenue.

Table of Content:

Chapter 1    Methodology & Scope

Chapter 2    Executive Summary

Chapter 3    Medical Fluid Bags Industry Insights

Chapter 4    Medical Fluid Bags Market, By Product

Chapter 5    Medical Fluid Bags Market, By Material

Chapter 6    Medical Fluid Bags Market, By End-Use

Chapter 7    Medical Fluid Bags Market, By Region

Chapter 8.   Company Profiles

More Report At: https://thechronicleindia.com/author/ashwin@marketstudyreport.com

Related Report:

United States Medical Fluid Bags Market Report 2018

In this report, the United States Medical Fluid Bags market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

https://www.marketstudyreport.com/reports/united-states-medical-fluid-bags-market-report-2018/?utm_source=RR-PSR

Outer Scope of this Report: The prevalence of a well-defined healthcare infrastructure and investments in lucrative projects by leading companies have helped this business space expand at an impressive rate. Recently for instance, Cryo-Cell International Inc., has introduced a blood freezer bag that marks the paradigm shift witnessed across the technological landscape of medical fluid bags market. Reports reveal that the blood freezer bag enables multiple uses of the infant’s cord blood stem cells and has increased stem cell viability by 10%. Other major firms operating in this business sphere are also expected to adopt R&D, M&As, and technological upgradation as their effective growth strategies. With further inevitable demand for saline bags, breast milk bags, enema bags, surgical & urinary drain bags from hospitals and homecare facilities, this industry space is expected to progress at an exceptional pace over the ensuing years.

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

Prenatal and New-born Genetic Testing Market Trend to 2024 Profiling Ariosa Diagnostics, Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom & More

Posted on Updated on

 

MarketStudyReport.com Adds New Prenatal and New-born Genetic Testing Market 2018 – 2024 research report providing information and By Technology, By Disease, By End-use, Industry Analysis, By Technology, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 140 Pages with table and figures in it.

Prenatal and New-born Genetic Testing Market Research Report for the period of 2018-2024 that shows the growth of the market is rising at a 11.9% CAGR to 2024.

Prenatal and New-born Genetic Testing Market will exceed USD 7 billion by 2024; as per a new research report. Technological advancement and several benefits associated with infant genetic testing will be major driver of the prenatal and new-born genetic testing market. Introduction of prenatal testing has led to substantial amount of increase in adoption rate of new testing technologies such as non-invasive prenatal testing (NIPT) for detection of sub chromosomal abnormalities, single-gene disorders and aneuploidy in North America region. Inclination towards minimally invasive infant genetic testing along with demand for early detection of birth defects will one of the major reason for market growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1130963/

Rising number of consanguineous relations in the developing countries of Asia and Middle East will foster growth opportunities for prenatal and newborn genetic testing market. The consanguineous relations are responsible for births of infants with defects and chromosomal abnormalities. Consequent, the increase in cases of live births diagnosed with birth defects will directly impact the growth of prenatal and new-born genetic testing market.

Increasing prevalence of birth defects among the European population is one of the major reason for rising infant mortality. The necessary government initiatives in order to conduct prenatal and new-born genetic tests to diagnose the birth defects will increase the number of infant screening programs giving rise to market growth opportunities.

Screening technology holds majority of market share in the year 2017 owing to increasing number of screening procedures of pregnant women while delivery. The rise in awareness among the families regarding genetic birth defects and early detection of genetic disorder will augment the segment growth in the near future.

Downs Syndrome recorded largest market share in the prenatal and newborn genetic testing market due to increasing in number of births diagnosed with Downs syndrome. The rise in incidences of women getting married at later stage of life is leading to increasing births with Downs Syndrome. These factors will further support the segment growth over the forecast timeframe.

Hospitals hold the majority of market share owing to increasing number of births in hospitals. Hospitals are aided by the government and provide the facilities require for the newborn screening. The increase in number of screening programs in hospitals provides significant scope for the market growth.

U.S. dominated the market in 2017 owing to ongoing technological advancements along with favorable reimbursement policies. The U.S. region had 99% of newborn screening rate and high awareness about prenatal and new-born genetic testing will be responsible for the market growth in U.S. Presence of technologically advanced and equipped manufacturing companies along with government initiatives supporting screening activities that will impel market growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1130963/

Some of the major market players competing in global prenatal and newborn genetic testing market are Ariosa Diagnostics (Roche), Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom, Trivitron Healthcare and Verinata health. The competitors are using launch of novel products with technological advancements, acquisitions and mergers as the key strategies to foresee a lucrative growth in prenatal and newborn genetic testing market. For example, In March 2018, Natera declared a partnership with QIAGEN to develop cell-free DNA assays for QIAGEN’s GeneReader NGS System. These DNA assays will be developed and designed for tests, including prenatal screening, for laboratories and hospitals globally.

Table of Content:

Chapter 1. Methodology

Chapter 2. Executive Summary

Chapter 3. Prenatal and New-born Genetic Testing Industry Insights

Chapter 4. Prenatal and New-born Genetic Testing Market, By Technology

Chapter 5. Prenatal and New-born Genetic Testing Market, By Disease

Chapter 6. Prenatal and New-born Genetic Testing Market, By End-use

Chapter 6. Prenatal and New-born Genetic Testing Market, By Region

Chapter 7. Company Profiles

For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

Related Report:

Global Prenatal and New-born Genetic Testing Market Size, Status and Forecast 2025

This report studies the global Prenatal and New-born Genetic Testing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Prenatal and New-born Genetic Testing market by companies, region, type and end-use industry.

https://www.marketstudyreport.com/reports/global-prenatal-and-new-born-genetic-testing-market-size-status-and-forecast-2025/?utm_source=RR-PSR

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

In-Vitro Colorectal Cancer Screening Tests Market Trend to 2024 Profiling Qiagen, Beckman Coulter, Siemens Healthcare, EMD Millipore, Alere, Abbott Molecular, Quest Diagnostics & more

Posted on

The 2017-2024 report on global In-Vitro Colorectal Cancer Screening Tests market explores the essential factors of In-Vitro Colorectal Cancer Screening Tests industry covering current scenario, market demand information, coverage of active companies and segmentation forecasts.

In-Vitro Colorectal Cancer Screening Tests Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 5% CAGR to 2024.

In-Vitro Colorectal Cancer Screening Tests market will exceed USD 1 billion by 2024; as per a new research report.Increasing incidences of colorectal cancer coupled with rising demand for non-invasive cancer screening tests will drive in-vitro colorectal cancer screening tests market over the forecast period. Growing geriatric population base, highly susceptible to suffer from colorectal cancer will further propel market growth.

Growing adoption of sedentary lifestyle, unhealthy dietary habits along with increased tobacco smoking and alcohol consumption has escalated number of people suffering from inflammatory intestinal conditions. Thus, leading to rise in colorectal cancer cases. Numerous initiatives undertaken by public as well as private players to create awareness about pre-diagnosis and treatment of colon and rectal cancer will favor industry growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467720/

Technological advancements in cancer screening tests delivering higher precision, accuracy in less time coupled with favorable reimbursement policies for colorectal cancer screening in developed countries such as U.S. will stimulate industry growth. However, lack of colorectal cancer screening guidelines and reimbursement in developing countries of Asia Pacific will hamper in-vitro colorectal cancer screening tests market growth over the forecast period.

Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness along with rising demand for non-invasive cancer screening tests will further fuel business growth.

High prevalence of colorectal cancer in the U.S., favorable reimbursement policies and technological advancements in cancer screening will drive U.S. in-vitro colorectal cancer screening tests market over the coming years. High adoption of unhealthy diet along with physical inactivity has led to rise in number of people suffering from chronic conditions such as obesity will propel business growth. Non-Hispanic Blacks and Alaskan citizens living in U.S., are at substantial risk of suffering from colorectal cancer will stimulate demand for invitro colorectal cancer screening tests.

Germany in-vitro colorectal cancer screening tests market was dominating the industry owing to large patient population and growing adoption of screening tests for preventing bowel cancer in the country. Changing lifestyle and food consumption pattern will positively impact market growth. Moreover, high technological adoption and favorable reimbursement policies for cancer screening will favor Germany in-vitro colorectal cancer screening tests market growth.

Several initiatives undertaken by Chinese government to create awareness about colorectal cancer to reduce disease burden coupled with rising number of baby boomers will drive China in-vitro colorectal cancer screening tests market. Growing disposable income and rendering unmet medical needs in the country will further stimulate business growth over the coming years.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467720/

Some of the notable industry players are Qiagen, Beckman Coulter, Siemens Healthcare, EMD Millipore, Alere, Abbott Molecular, Quest Diagnostics and Sysmex Corporation among others.

Major industry players are focusing on developing superior non-invasive techniques for screening of colorectal cancer to gain significant market share as well as sustain its position in the market. Inorganic growth strategies such as merger and acquisition, along with strategic partnership and collaboration are undertaken by industry players to strengthen product portfolio and expand customer base.

Table of Content:

Chapter 1. Methodology

Chapter 2. Executive Summary

Chapter 3. In-Vitro Colorectal Cancer Screening Tests Industry Insights

Chapter 4. In-Vitro Colorectal Cancer Screening Tests Market, By Test Type

Chapter 5. In-Vitro Colorectal Cancer Screening Tests Market, By Region

Chapter 6. Company Profiles

For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

Related Report:

Global In-vitro Colorectal Cancer Screening Tests Market Size, Status and Forecast 2025

In 2017, the global In-vitro Colorectal Cancer Screening Tests market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

https://www.marketstudyreport.com/reports/global-in-vitro-colorectal-cancer-screening-tests-market-size-status-and-forecast-2025/?utm_source=RR-PSR

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog